Related Experiment Video
Updated: Jun 10, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Cathepsin D messenger RNA is downregulated in human lung cancer
Andrey V Shubin1, Ilya V Demidyuk, Alexander M Kurinov
1Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia.
Objectives:
Lysosomal proteases cathepsins B and D (CB and CD) play a significant part in cancer progression. For many oncological diseases protein expression levels of CB and CD have been investigated and correlations with tumour characteristics revealed. Meanwhile, there is very little information concerning mRNA expression level.
Methods:
In the present work, data about mRNA levels of CB and CD in human lung cancer was obtained using reverse transcription followed by real-time polymerase chain reaction.
Results:
For the first time CD and CB mRNA in human lung cancer tumours was quantified. It was shown that CB and CD mRNA levels do not correlate with any tumour characteristics. However, in most analysed tumours, expression of CD mRNA was downregulated compared with adjacent normal tissue (p <0.0003).
Conclusions:
The data obtained indicate CD mRNA as a potential lung cancer marker.
Insights
Cathepsin D (CD) mRNA expression is downregulated in most human lung cancers compared to normal tissue. This finding suggests CD mRNA may serve as a potential biomarker for lung cancer detection.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Lysosomal proteases, cathepsin B (CB) and cathepsin D (CD), are implicated in cancer progression.
- While protein levels of CB and CD have been studied in various cancers, their mRNA expression in lung cancer remains underexplored.
Purpose of the Study:
- To investigate the mRNA expression levels of cathepsin D (CD) and cathepsin B (CB) in human lung cancer.
- To determine the correlation between CD and CB mRNA levels and tumor characteristics.
Main Methods:
- Quantification of CD and CB mRNA in human lung cancer tissues and adjacent normal tissues.
- Utilized reverse transcription and real-time polymerase chain reaction (RT-qPCR) for mRNA analysis.
Main Results:
- CD and CB mRNA levels did not correlate with any assessed tumor characteristics.
- A significant downregulation of CD mRNA was observed in the majority of analyzed lung tumors compared to adjacent normal tissue (p <0.0003).
Conclusions:
- The study identified a significant downregulation of CD mRNA in lung cancer.
- CD mRNA presents potential as a novel biomarker for lung cancer diagnosis.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs